GlassScriptPhysician profile
Marissa Brianne Quehl
NPI 1093466310
$4,030.81
in general payments reported to CMS, 2019-2025
39 companies · $818 in 2025
The $818 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $970 · 2023: $1,488 · 2024: $754 · 2025: $818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,871 · Education: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,871.43 |
| Education | $189.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $616.79 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $448.00 | 2022-2025 | Veozah |
| Glaxosmithkline, LLC. | $386.25 | 2022-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $310.82 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $257.49 | 2022-2023 | |
| Abbvie INC. | $222.78 | 2022-2025 | |
| Amgen INC. | $197.24 | 2022-2025 | Repatha, Otezla, Otezla |
| Pfizer INC. | $180.61 | 2023-2025 | |
| Antares Pharma, INC. | $127.91 | 2022-2024 | Xyosted, Nocdurna, Tlando |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.81 | 2024-2025 | Ofev |
| Astrazeneca Pharmaceuticals LP | $85.30 | 2022-2024 | Breztri, Airsupra |
| Merck Sharp & Dohme LLC | $79.89 | 2022 | |
| Sumitomo Pharma America, INC. | $77.55 | 2025 | Gemtesa |
| Idorsia Pharmaceuticals US INC | $75.45 | 2022-2024 | Quviviq |
| Halozyme INC | $68.87 | 2023 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $64.54 | 2022-2023 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $62.99 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $62.46 | 2022 | |
| Tris Pharma INC | $53.81 | 2022-2023 | Dyanavel Xr |
| Medtronic, INC. | $51.70 | 2024 | Venaseal |
| Ironshore Pharmaceuticals INC. | $47.11 | 2023 | Jornay Pm |
| Teva Pharmaceuticals USA, INC. | $43.53 | 2022 | |
| Janssen Pharmaceuticals, INC | $42.59 | 2022-2025 | Spravato |
| Dynavax Technologies Corporation | $38.08 | 2022-2023 | Heplisav-B |
| Novartis Pharmaceuticals Corporation | $35.61 | 2022-2023 | |
| Inspire Medical Systems, INC. | $31.98 | 2025 | Inspire |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.38 | 2022-2024 | Xifaxan |
| Corium, LLC | $27.86 | 2023 | Azstarys |
| Inari Medical, INC. | $26.47 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Inogen, INC. | $23.62 | 2025 | |
| Amarin Pharma, INC. | $22.81 | 2022 | |
| Philips North America LLC | $22.14 | 2024 | (Ck7) Extended Holter |
| Boston Scientific Corporation | $22.00 | 2024 | |
| Gilead Sciences, INC. | $20.19 | 2025 | |
| Ironwood Pharmaceuticals, INC | $17.93 | 2023 | Linzess |
| Esperion Therapeutics, INC. | $17.34 | 2022 | |
| Almatica Pharma LLC | $16.81 | 2023 | Gralise, Loreev Xr |
| Recor Medical INC | $15.99 | 2024 | Paradise Renal Denervation System |
| Echosens North America, INC. | $10.11 | 2025 | Fibroscan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marissa Quehl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.